<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/mt/journal/vaop/ncurrent/rss.rdf">
<title>Molecular Therapy</title>
<description/>
<link>http://www.nature.com/mt/journal/vaop/ncurrent/rss.rdf</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>Copyright &#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:issn>1525-0016</prism:issn>
<prism:copyright>Copyright &#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/mt.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.93"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.85"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.86"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.91"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.87"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.92"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.81"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.84"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.88"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.77"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.82"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.83"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.69"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.64"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.79"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.72"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.62"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.73"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.76"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.68"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.63"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.67"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.66"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.60"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.58"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.54"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.57"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.61"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.59"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.56"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.mt.6300415"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.7"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.mt.6300420"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/mt.2008.11"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.mt.6300416"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.mt.6300409"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.mt.6300407"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.mt.6300410"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/mt.gif">
<title>Molecular Therapy</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/mt.gif</url>
<link>http://www.nature.com/mt/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.93">
<title>In Vivo Biosafety Model to Assess the Risk of Adverse Events From Retroviral and Lentiviral Vectors</title>
<link>http://dx.doi.org/10.1038/mt.2008.93</link>
<content:encoded><![CDATA[

<p>
<b>In Vivo Biosafety Model to Assess the Risk of Adverse Events From Retroviral and Lentiviral Vectors</b>
</p>
<p>Molecular Therapy advance online publication, May 6, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.93">doi:10.1038/mt.2008.93</a>
</p>
<p>Authors: Gerhard Bauer, Mo A Dao, Scott S Case, Todd Meyerrose, Louisa Wirthlin, Ping Zhou, Xiuli Wang, Phillip Herrbrich, Jesusa Arevalo, Susie Csik, Dianne C Skelton, Jon Walker, Karen Pepper, Donald B Kohn
&amp; Jan A Nolta</p>
]]></content:encoded>
<dc:title>In Vivo Biosafety Model to Assess the Risk of Adverse Events From Retroviral and Lentiviral Vectors</dc:title>
<dc:creator>Gerhard Bauer</dc:creator>
<dc:creator>Mo A Dao</dc:creator>
<dc:creator>Scott S Case</dc:creator>
<dc:creator>Todd Meyerrose</dc:creator>
<dc:creator>Louisa Wirthlin</dc:creator>
<dc:creator>Ping Zhou</dc:creator>
<dc:creator>Xiuli Wang</dc:creator>
<dc:creator>Phillip Herrbrich</dc:creator>
<dc:creator>Jesusa Arevalo</dc:creator>
<dc:creator>Susie Csik</dc:creator>
<dc:creator>Dianne C Skelton</dc:creator>
<dc:creator>Jon Walker</dc:creator>
<dc:creator>Karen Pepper</dc:creator>
<dc:creator>Donald B Kohn</dc:creator>
<dc:creator>Jan A Nolta</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.93</dc:identifier>
<dc:source>Molecular Therapy advance online publication, May 6, 2008</dc:source>
<dc:date>May 6, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>May 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.85">
<title>An Endogenous TNF-&#945; Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models</title>
<link>http://dx.doi.org/10.1038/mt.2008.85</link>
<content:encoded><![CDATA[

<p>
<b>An Endogenous TNF-&#945; Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models</b>
</p>
<p>Molecular Therapy advance online publication, May 6, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.85">doi:10.1038/mt.2008.85</a>
</p>
<p>Authors: Maria A Graziewicz, Teresa K Tarrant, Brian Buckley, Jennifer Roberts, LeShara Fulton, Henrik Hansen, Henrik &#216;rum, Ryszard Kole
&amp; Peter Sazani</p>
]]></content:encoded>
<dc:title>An Endogenous TNF-&#945; Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models</dc:title>
<dc:creator>Maria A Graziewicz</dc:creator>
<dc:creator>Teresa K Tarrant</dc:creator>
<dc:creator>Brian Buckley</dc:creator>
<dc:creator>Jennifer Roberts</dc:creator>
<dc:creator>LeShara Fulton</dc:creator>
<dc:creator>Henrik Hansen</dc:creator>
<dc:creator>Henrik &#216;rum</dc:creator>
<dc:creator>Ryszard Kole</dc:creator>
<dc:creator>Peter Sazani</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.85</dc:identifier>
<dc:source>Molecular Therapy advance online publication, May 6, 2008</dc:source>
<dc:date>May 6, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>May 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.86">
<title>Modification of Adenoviral Vectors With Polyethylene Glycol Modulates In Vivo Tissue Tropism and Gene Expression</title>
<link>http://dx.doi.org/10.1038/mt.2008.86</link>
<content:encoded><![CDATA[

<p>
<b>Modification of Adenoviral Vectors With Polyethylene Glycol Modulates In Vivo Tissue Tropism and Gene Expression</b>
</p>
<p>Molecular Therapy advance online publication, May 6, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.86">doi:10.1038/mt.2008.86</a>
</p>
<p>Authors: Sean E Hofherr, Elena V Shashkova, Eric A Weaver, Reeti Khare
&amp; Michael A Barry</p>
]]></content:encoded>
<dc:title>Modification of Adenoviral Vectors With Polyethylene Glycol Modulates In Vivo Tissue Tropism and Gene Expression</dc:title>
<dc:creator>Sean E Hofherr</dc:creator>
<dc:creator>Elena V Shashkova</dc:creator>
<dc:creator>Eric A Weaver</dc:creator>
<dc:creator>Reeti Khare</dc:creator>
<dc:creator>Michael A Barry</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.86</dc:identifier>
<dc:source>Molecular Therapy advance online publication, May 6, 2008</dc:source>
<dc:date>May 6, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>May 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.91">
<title>Topical Application of Cream-emulsified CD86 siRNA Ameliorates Allergic Skin Disease by Targeting Cutaneous Dendritic Cells</title>
<link>http://dx.doi.org/10.1038/mt.2008.91</link>
<content:encoded><![CDATA[

<p>
<b>Topical Application of Cream-emulsified CD86 siRNA Ameliorates Allergic Skin Disease by Targeting Cutaneous Dendritic Cells</b>
</p>
<p>Molecular Therapy advance online publication, May 6, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.91">doi:10.1038/mt.2008.91</a>
</p>
<p>Authors: Patcharee Ritprajak, Masaaki Hashiguchi
&amp; Miyuki Azuma</p>
]]></content:encoded>
<dc:title>Topical Application of Cream-emulsified CD86 siRNA Ameliorates Allergic Skin Disease by Targeting Cutaneous Dendritic Cells</dc:title>
<dc:creator>Patcharee Ritprajak</dc:creator>
<dc:creator>Masaaki Hashiguchi</dc:creator>
<dc:creator>Miyuki Azuma</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.91</dc:identifier>
<dc:source>Molecular Therapy advance online publication, May 6, 2008</dc:source>
<dc:date>May 6, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>May 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.87">
<title>Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle</title>
<link>http://dx.doi.org/10.1038/mt.2008.87</link>
<content:encoded><![CDATA[

<p>
<b>Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle</b>
</p>
<p>Molecular Therapy advance online publication, May 6, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.87">doi:10.1038/mt.2008.87</a>
</p>
<p>Authors: Alice Toromanoff, Yan Ch&#233;rel, Micka&#235;l Guilbaud, Magalie Penaud-Budloo, Richard O Snyder, Mark E Haskins, Jack-Yves Deschamps, Lydie Guigand, Guillaume Podevin, Valder R Arruda, Katherine A High, Hansell H Stedman, Fabienne Rolling, Ignacio Anegon, Philippe Moullier
&amp; Caroline Le Guiner</p>
]]></content:encoded>
<dc:title>Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle</dc:title>
<dc:creator>Alice Toromanoff</dc:creator>
<dc:creator>Yan Ch&#233;rel</dc:creator>
<dc:creator>Micka&#235;l Guilbaud</dc:creator>
<dc:creator>Magalie Penaud-Budloo</dc:creator>
<dc:creator>Richard O Snyder</dc:creator>
<dc:creator>Mark E Haskins</dc:creator>
<dc:creator>Jack-Yves Deschamps</dc:creator>
<dc:creator>Lydie Guigand</dc:creator>
<dc:creator>Guillaume Podevin</dc:creator>
<dc:creator>Valder R Arruda</dc:creator>
<dc:creator>Katherine A High</dc:creator>
<dc:creator>Hansell H Stedman</dc:creator>
<dc:creator>Fabienne Rolling</dc:creator>
<dc:creator>Ignacio Anegon</dc:creator>
<dc:creator>Philippe Moullier</dc:creator>
<dc:creator>Caroline Le Guiner</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.87</dc:identifier>
<dc:source>Molecular Therapy advance online publication, May 6, 2008</dc:source>
<dc:date>May 6, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>May 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.92">
<title>Novel Dual Inhibitory Function Aptamer&#8211;siRNA Delivery System for HIV-1 Therapy</title>
<link>http://dx.doi.org/10.1038/mt.2008.92</link>
<content:encoded><![CDATA[

<p>
<b>Novel Dual Inhibitory Function Aptamer&#8211;siRNA Delivery System for HIV-1 Therapy</b>
</p>
<p>Molecular Therapy advance online publication, May 6, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.92">doi:10.1038/mt.2008.92</a>
</p>
<p>Authors: Jiehua Zhou, Haitang Li, Shirley Li, John Zaia
&amp; John J Rossi</p>
]]></content:encoded>
<dc:title>Novel Dual Inhibitory Function Aptamer&#8211;siRNA Delivery System for HIV-1 Therapy</dc:title>
<dc:creator>Jiehua Zhou</dc:creator>
<dc:creator>Haitang Li</dc:creator>
<dc:creator>Shirley Li</dc:creator>
<dc:creator>John Zaia</dc:creator>
<dc:creator>John J Rossi</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.92</dc:identifier>
<dc:source>Molecular Therapy advance online publication, May 6, 2008</dc:source>
<dc:date>May 6, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>May 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.81">
<title>Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice</title>
<link>http://dx.doi.org/10.1038/mt.2008.81</link>
<content:encoded><![CDATA[

<p>
<b>Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice</b>
</p>
<p>Molecular Therapy advance online publication, April 29, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.81">doi:10.1038/mt.2008.81</a>
</p>
<p>Authors: Shen-Hao Lai, David A Stein, Antonieta Guerrero-Plata, Sui-Ling Liao, Teodora Ivanciuc, Chao Hong, Patrick L Iversen, Antonella Casola
&amp; Roberto P Garofalo</p>
]]></content:encoded>
<dc:title>Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice</dc:title>
<dc:creator>Shen-Hao Lai</dc:creator>
<dc:creator>David A Stein</dc:creator>
<dc:creator>Antonieta Guerrero-Plata</dc:creator>
<dc:creator>Sui-Ling Liao</dc:creator>
<dc:creator>Teodora Ivanciuc</dc:creator>
<dc:creator>Chao Hong</dc:creator>
<dc:creator>Patrick L Iversen</dc:creator>
<dc:creator>Antonella Casola</dc:creator>
<dc:creator>Roberto P Garofalo</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.81</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 29, 2008</dc:source>
<dc:date>April 29, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 29, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.84">
<title>Mannose 6-Phosphate Receptor&#8211;mediated Transport of Sulfamidase Across the Blood&#8211;brain Barrier in the Newborn Mouse</title>
<link>http://dx.doi.org/10.1038/mt.2008.84</link>
<content:encoded><![CDATA[

<p>
<b>Mannose 6-Phosphate Receptor&#8211;mediated Transport of Sulfamidase Across the Blood&#8211;brain Barrier in the Newborn Mouse</b>
</p>
<p>Molecular Therapy advance online publication, April 29, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.84">doi:10.1038/mt.2008.84</a>
</p>
<p>Authors: Akihiko Urayama, Jeffrey H Grubb, William S Sly
&amp; William A Banks</p>
]]></content:encoded>
<dc:title>Mannose 6-Phosphate Receptor&#8211;mediated Transport of Sulfamidase Across the Blood&#8211;brain Barrier in the Newborn Mouse</dc:title>
<dc:creator>Akihiko Urayama</dc:creator>
<dc:creator>Jeffrey H Grubb</dc:creator>
<dc:creator>William S Sly</dc:creator>
<dc:creator>William A Banks</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.84</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 29, 2008</dc:source>
<dc:date>April 29, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 29, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.88">
<title>A Critical Role for Type I IFN&#8211;dependent NK Cell Activation in Innate Immune Elimination of Adenoviral Vectors In Vivo</title>
<link>http://dx.doi.org/10.1038/mt.2008.88</link>
<content:encoded><![CDATA[

<p>
<b>A Critical Role for Type I IFN&#8211;dependent NK Cell Activation in Innate Immune Elimination of Adenoviral Vectors In Vivo</b>
</p>
<p>Molecular Therapy advance online publication, April 29, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.88">doi:10.1038/mt.2008.88</a>
</p>
<p>Authors: Jiangao Zhu, Xiaopei Huang
&amp; Yiping Yang</p>
]]></content:encoded>
<dc:title>A Critical Role for Type I IFN&#8211;dependent NK Cell Activation in Innate Immune Elimination of Adenoviral Vectors In Vivo</dc:title>
<dc:creator>Jiangao Zhu</dc:creator>
<dc:creator>Xiaopei Huang</dc:creator>
<dc:creator>Yiping Yang</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.88</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 29, 2008</dc:source>
<dc:date>April 29, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 29, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.77">
<title>Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA</title>
<link>http://dx.doi.org/10.1038/mt.2008.77</link>
<content:encoded><![CDATA[

<p>
<b>Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA</b>
</p>
<p>Molecular Therapy advance online publication, April 22, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.77">doi:10.1038/mt.2008.77</a>
</p>
<p>Authors: Aude Bonehill, Sandra Tuyaerts, An MT Van Nuffel, Carlo Heirman, Tomas J Bos, Karel Fostier, Bart Neyns
&amp; Kris Thielemans</p>
]]></content:encoded>
<dc:title>Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA</dc:title>
<dc:creator>Aude Bonehill</dc:creator>
<dc:creator>Sandra Tuyaerts</dc:creator>
<dc:creator>An MT Van Nuffel</dc:creator>
<dc:creator>Carlo Heirman</dc:creator>
<dc:creator>Tomas J Bos</dc:creator>
<dc:creator>Karel Fostier</dc:creator>
<dc:creator>Bart Neyns</dc:creator>
<dc:creator>Kris Thielemans</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.77</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 22, 2008</dc:source>
<dc:date>April 22, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.82">
<title>Expressed Anti-HBV Primary MicroRNA Shuttles Inhibit Viral Replication Efficiently In Vitro and In Vivo</title>
<link>http://dx.doi.org/10.1038/mt.2008.82</link>
<content:encoded><![CDATA[

<p>
<b>Expressed Anti-HBV Primary MicroRNA Shuttles Inhibit Viral Replication Efficiently In Vitro and In Vivo</b>
</p>
<p>Molecular Therapy advance online publication, April 22, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.82">doi:10.1038/mt.2008.82</a>
</p>
<p>Authors: Abdullah Ely, Tanusha Naidoo, Steven Mufamadi, Carol Crowther
&amp; Patrick Arbuthnot</p>
]]></content:encoded>
<dc:title>Expressed Anti-HBV Primary MicroRNA Shuttles Inhibit Viral Replication Efficiently In Vitro and In Vivo</dc:title>
<dc:creator>Abdullah Ely</dc:creator>
<dc:creator>Tanusha Naidoo</dc:creator>
<dc:creator>Steven Mufamadi</dc:creator>
<dc:creator>Carol Crowther</dc:creator>
<dc:creator>Patrick Arbuthnot</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.82</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 22, 2008</dc:source>
<dc:date>April 22, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.83">
<title>Treg Depletion&#8211;enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus</title>
<link>http://dx.doi.org/10.1038/mt.2008.83</link>
<content:encoded><![CDATA[

<p>
<b>Treg Depletion&#8211;enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus</b>
</p>
<p>Molecular Therapy advance online publication, April 22, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.83">doi:10.1038/mt.2008.83</a>
</p>
<p>Authors: Timothy Kottke, Feorillo Galivo, Phonphimon Wongthida, Rosa Maria Diaz, Jill Thompson, Dragan Jevremovic, Glen N Barber, Geoff Hall, John Chester, Peter Selby, Kevin Harrington, Alan Melcher
&amp; Richard G Vile</p>
]]></content:encoded>
<dc:title>Treg Depletion&#8211;enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus</dc:title>
<dc:creator>Timothy Kottke</dc:creator>
<dc:creator>Feorillo Galivo</dc:creator>
<dc:creator>Phonphimon Wongthida</dc:creator>
<dc:creator>Rosa Maria Diaz</dc:creator>
<dc:creator>Jill Thompson</dc:creator>
<dc:creator>Dragan Jevremovic</dc:creator>
<dc:creator>Glen N Barber</dc:creator>
<dc:creator>Geoff Hall</dc:creator>
<dc:creator>John Chester</dc:creator>
<dc:creator>Peter Selby</dc:creator>
<dc:creator>Kevin Harrington</dc:creator>
<dc:creator>Alan Melcher</dc:creator>
<dc:creator>Richard G Vile</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.83</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 22, 2008</dc:source>
<dc:date>April 22, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.69">
<title>Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-&#947; in a Murine Model of Progressive Pulmonary Tuberculosis</title>
<link>http://dx.doi.org/10.1038/mt.2008.69</link>
<content:encoded><![CDATA[

<p>
<b>Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-&#947; in a Murine Model of Progressive Pulmonary Tuberculosis</b>
</p>
<p>Molecular Therapy advance online publication, April 22, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.69">doi:10.1038/mt.2008.69</a>
</p>
<p>Authors: Dulce A Mata-Espinosa, Valentin Mendoza-Rodr&#237;guez, Diana Aguilar-Le&#243;n, Ricardo Rosales, Fernando L&#243;pez-Casillas
&amp; Rogelio Hern&#225;ndez-Pando</p>
]]></content:encoded>
<dc:title>Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-&#947; in a Murine Model of Progressive Pulmonary Tuberculosis</dc:title>
<dc:creator>Dulce A Mata-Espinosa</dc:creator>
<dc:creator>Valentin Mendoza-Rodr&#237;guez</dc:creator>
<dc:creator>Diana Aguilar-Le&#243;n</dc:creator>
<dc:creator>Ricardo Rosales</dc:creator>
<dc:creator>Fernando L&#243;pez-Casillas</dc:creator>
<dc:creator>Rogelio Hern&#225;ndez-Pando</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.69</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 22, 2008</dc:source>
<dc:date>April 22, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.64">
<title>Adult Bone Marrow&#8211;derived Cells Do Not Acquire Functional Attributes of Cardiomyocytes When Transplanted into Peri-infarct Myocardium</title>
<link>http://dx.doi.org/10.1038/mt.2008.64</link>
<content:encoded><![CDATA[

<p>
<b>Adult Bone Marrow&#8211;derived Cells Do Not Acquire Functional Attributes of Cardiomyocytes When Transplanted into Peri-infarct Myocardium</b>
</p>
<p>Molecular Therapy advance online publication, April 22, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.64">doi:10.1038/mt.2008.64</a>
</p>
<p>Authors: John A Scherschel, Mark H Soonpaa, Edward F Srour, Loren J Field
&amp; Michael Rubart</p>
]]></content:encoded>
<dc:title>Adult Bone Marrow&#8211;derived Cells Do Not Acquire Functional Attributes of Cardiomyocytes When Transplanted into Peri-infarct Myocardium</dc:title>
<dc:creator>John A Scherschel</dc:creator>
<dc:creator>Mark H Soonpaa</dc:creator>
<dc:creator>Edward F Srour</dc:creator>
<dc:creator>Loren J Field</dc:creator>
<dc:creator>Michael Rubart</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.64</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 22, 2008</dc:source>
<dc:date>April 22, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.79">
<title>Regulated Insulin Delivery From Human Epidermal Cells Reverses Hyperglycemia</title>
<link>http://dx.doi.org/10.1038/mt.2008.79</link>
<content:encoded><![CDATA[

<p>
<b>Regulated Insulin Delivery From Human Epidermal Cells Reverses Hyperglycemia</b>
</p>
<p>Molecular Therapy advance online publication, April 22, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.79">doi:10.1038/mt.2008.79</a>
</p>
<p>Authors: Jun Tian, Pedro Lei, Suzanne G Laychock
&amp; Stelios T Andreadis</p>
]]></content:encoded>
<dc:title>Regulated Insulin Delivery From Human Epidermal Cells Reverses Hyperglycemia</dc:title>
<dc:creator>Jun Tian</dc:creator>
<dc:creator>Pedro Lei</dc:creator>
<dc:creator>Suzanne G Laychock</dc:creator>
<dc:creator>Stelios T Andreadis</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.79</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 22, 2008</dc:source>
<dc:date>April 22, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.72">
<title>Gene Delivery to the Juvenile Mouse Liver Using AAV2/8 Vectors</title>
<link>http://dx.doi.org/10.1038/mt.2008.72</link>
<content:encoded><![CDATA[

<p>
<b>Gene Delivery to the Juvenile Mouse Liver Using AAV2/8 Vectors</b>
</p>
<p>Molecular Therapy advance online publication, April 15, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.72">doi:10.1038/mt.2008.72</a>
</p>
<p>Authors: Sharon C Cunningham, Allison P Dane, Afroditi Spinoulas
&amp; Ian E Alexander</p>
]]></content:encoded>
<dc:title>Gene Delivery to the Juvenile Mouse Liver Using AAV2/8 Vectors</dc:title>
<dc:creator>Sharon C Cunningham</dc:creator>
<dc:creator>Allison P Dane</dc:creator>
<dc:creator>Afroditi Spinoulas</dc:creator>
<dc:creator>Ian E Alexander</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.72</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 15, 2008</dc:source>
<dc:date>April 15, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 15, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.62">
<title>Treatment of Obesity and Diabetes in Mice by Transplant of Gut Cells Engineered to Produce Leptin</title>
<link>http://dx.doi.org/10.1038/mt.2008.62</link>
<content:encoded><![CDATA[

<p>
<b>Treatment of Obesity and Diabetes in Mice by Transplant of Gut Cells Engineered to Produce Leptin</b>
</p>
<p>Molecular Therapy advance online publication, April 15, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.62">doi:10.1038/mt.2008.62</a>
</p>
<p>Authors: Sarah N Oosman, Ada W Lam, George Harb, Suraj Unniappan, Ni T Lam, Travis Webber, Daniel Bruch, Qiu-Xia Zhang, Gregory S Korbutt
&amp; Timothy J Kieffer</p>
]]></content:encoded>
<dc:title>Treatment of Obesity and Diabetes in Mice by Transplant of Gut Cells Engineered to Produce Leptin</dc:title>
<dc:creator>Sarah N Oosman</dc:creator>
<dc:creator>Ada W Lam</dc:creator>
<dc:creator>George Harb</dc:creator>
<dc:creator>Suraj Unniappan</dc:creator>
<dc:creator>Ni T Lam</dc:creator>
<dc:creator>Travis Webber</dc:creator>
<dc:creator>Daniel Bruch</dc:creator>
<dc:creator>Qiu-Xia Zhang</dc:creator>
<dc:creator>Gregory S Korbutt</dc:creator>
<dc:creator>Timothy J Kieffer</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.62</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 15, 2008</dc:source>
<dc:date>April 15, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 15, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.73">
<title>Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice</title>
<link>http://dx.doi.org/10.1038/mt.2008.73</link>
<content:encoded><![CDATA[

<p>
<b>Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice</b>
</p>
<p>Molecular Therapy advance online publication, April 15, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.73">doi:10.1038/mt.2008.73</a>
</p>
<p>Authors: Chris Towne, C&#233;dric Raoul, Bernard L Schneider
&amp; Patrick Aebischer</p>
]]></content:encoded>
<dc:title>Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice</dc:title>
<dc:creator>Chris Towne</dc:creator>
<dc:creator>C&#233;dric Raoul</dc:creator>
<dc:creator>Bernard L Schneider</dc:creator>
<dc:creator>Patrick Aebischer</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.73</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 15, 2008</dc:source>
<dc:date>April 15, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 15, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.76">
<title>Analysis of AAV Serotypes 1&#8211;9 Mediated Gene Expression and Tropism in Mice After Systemic Injection</title>
<link>http://dx.doi.org/10.1038/mt.2008.76</link>
<content:encoded><![CDATA[

<p>
<b>Analysis of AAV Serotypes 1&#8211;9 Mediated Gene Expression and Tropism in Mice After Systemic Injection</b>
</p>
<p>Molecular Therapy advance online publication, April 15, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.76">doi:10.1038/mt.2008.76</a>
</p>
<p>Authors: Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo
&amp; Joseph E Rabinowitz</p>
]]></content:encoded>
<dc:title>Analysis of AAV Serotypes 1&#8211;9 Mediated Gene Expression and Tropism in Mice After Systemic Injection</dc:title>
<dc:creator>Carmela Zincarelli</dc:creator>
<dc:creator>Stephen Soltys</dc:creator>
<dc:creator>Giuseppe Rengo</dc:creator>
<dc:creator>Joseph E Rabinowitz</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.76</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 15, 2008</dc:source>
<dc:date>April 15, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 15, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.68">
<title>HSP70 and Constitutively Active HSF1 Mediate Protection Against CDCrel-1-mediated Toxicity</title>
<link>http://dx.doi.org/10.1038/mt.2008.68</link>
<content:encoded><![CDATA[

<p>
<b>HSP70 and Constitutively Active HSF1 Mediate Protection Against CDCrel-1-mediated Toxicity</b>
</p>
<p>Molecular Therapy advance online publication, April 8, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.68">doi:10.1038/mt.2008.68</a>
</p>
<p>Authors: Alisha E Jung, Helen L Fitzsimons, Ross J Bland, Matthew J During
&amp; Deborah Young</p>
]]></content:encoded>
<dc:title>HSP70 and Constitutively Active HSF1 Mediate Protection Against CDCrel-1-mediated Toxicity</dc:title>
<dc:creator>Alisha E Jung</dc:creator>
<dc:creator>Helen L Fitzsimons</dc:creator>
<dc:creator>Ross J Bland</dc:creator>
<dc:creator>Matthew J During</dc:creator>
<dc:creator>Deborah Young</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.68</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 8, 2008</dc:source>
<dc:date>April 8, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.63">
<title>Novel Cancer Antiangiotherapy Using the VEGF Promoter-targeted Artificial Zinc-finger Protein and Oncolytic Adenovirus</title>
<link>http://dx.doi.org/10.1038/mt.2008.63</link>
<content:encoded><![CDATA[

<p>
<b>Novel Cancer Antiangiotherapy Using the VEGF Promoter-targeted Artificial Zinc-finger Protein and Oncolytic Adenovirus</b>
</p>
<p>Molecular Therapy advance online publication, April 8, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.63">doi:10.1038/mt.2008.63</a>
</p>
<p>Authors: Yoon-A Kang, Hyun-Chul Shin, Ji Young Yoo, Joo-Hang Kim, Jin-Soo Kim
&amp; Chae-Ok Yun</p>
]]></content:encoded>
<dc:title>Novel Cancer Antiangiotherapy Using the VEGF Promoter-targeted Artificial Zinc-finger Protein and Oncolytic Adenovirus</dc:title>
<dc:creator>Yoon-A Kang</dc:creator>
<dc:creator>Hyun-Chul Shin</dc:creator>
<dc:creator>Ji Young Yoo</dc:creator>
<dc:creator>Joo-Hang Kim</dc:creator>
<dc:creator>Jin-Soo Kim</dc:creator>
<dc:creator>Chae-Ok Yun</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.63</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 8, 2008</dc:source>
<dc:date>April 8, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.67">
<title>Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca&#8211;/&#8211; Hematopoietic Stem Cells</title>
<link>http://dx.doi.org/10.1038/mt.2008.67</link>
<content:encoded><![CDATA[

<p>
<b>Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca&#8211;/&#8211; Hematopoietic Stem Cells</b>
</p>
<p>Molecular Therapy advance online publication, April 8, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.67">doi:10.1038/mt.2008.67</a>
</p>
<p>Authors: Lars UW M&#252;ller, Michael D Milsom, Mi-Ok Kim, Axel Schambach, Todd Schuesler
&amp; David A Williams</p>
]]></content:encoded>
<dc:title>Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca&#8211;/&#8211; Hematopoietic Stem Cells</dc:title>
<dc:creator>Lars UW M&#252;ller</dc:creator>
<dc:creator>Michael D Milsom</dc:creator>
<dc:creator>Mi-Ok Kim</dc:creator>
<dc:creator>Axel Schambach</dc:creator>
<dc:creator>Todd Schuesler</dc:creator>
<dc:creator>David A Williams</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.67</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 8, 2008</dc:source>
<dc:date>April 8, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.66">
<title>Computer-assisted Hydrodynamic Gene Delivery</title>
<link>http://dx.doi.org/10.1038/mt.2008.66</link>
<content:encoded><![CDATA[

<p>
<b>Computer-assisted Hydrodynamic Gene Delivery</b>
</p>
<p>Molecular Therapy advance online publication, April 8, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.66">doi:10.1038/mt.2008.66</a>
</p>
<p>Authors: Takeshi Suda, Kieko Suda
&amp; Dexi Liu</p>
]]></content:encoded>
<dc:title>Computer-assisted Hydrodynamic Gene Delivery</dc:title>
<dc:creator>Takeshi Suda</dc:creator>
<dc:creator>Kieko Suda</dc:creator>
<dc:creator>Dexi Liu</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.66</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 8, 2008</dc:source>
<dc:date>April 8, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.60">
<title>Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity</title>
<link>http://dx.doi.org/10.1038/mt.2008.60</link>
<content:encoded><![CDATA[

<p>
<b>Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity</b>
</p>
<p>Molecular Therapy advance online publication, April 1, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.60">doi:10.1038/mt.2008.60</a>
</p>
<p>Authors: James C Dodge, Amanda M Haidet, Wendy Yang, Marco A Passini, Mark Hester, Jennifer Clarke, Eric M Roskelley, Christopher M Treleaven, Liza Rizo, Heather Martin, Soo H Kim, Rita Kaspar, Tatyana V Taksir, Denise A Griffiths, Seng H Cheng, Lamya S Shihabuddin
&amp; Brian K Kaspar</p>
]]></content:encoded>
<dc:title>Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity</dc:title>
<dc:creator>James C Dodge</dc:creator>
<dc:creator>Amanda M Haidet</dc:creator>
<dc:creator>Wendy Yang</dc:creator>
<dc:creator>Marco A Passini</dc:creator>
<dc:creator>Mark Hester</dc:creator>
<dc:creator>Jennifer Clarke</dc:creator>
<dc:creator>Eric M Roskelley</dc:creator>
<dc:creator>Christopher M Treleaven</dc:creator>
<dc:creator>Liza Rizo</dc:creator>
<dc:creator>Heather Martin</dc:creator>
<dc:creator>Soo H Kim</dc:creator>
<dc:creator>Rita Kaspar</dc:creator>
<dc:creator>Tatyana V Taksir</dc:creator>
<dc:creator>Denise A Griffiths</dc:creator>
<dc:creator>Seng H Cheng</dc:creator>
<dc:creator>Lamya S Shihabuddin</dc:creator>
<dc:creator>Brian K Kaspar</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.60</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 1, 2008</dc:source>
<dc:date>April 1, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.58">
<title>Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects</title>
<link>http://dx.doi.org/10.1038/mt.2008.58</link>
<content:encoded><![CDATA[

<p>
<b>Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects</b>
</p>
<p>Molecular Therapy advance online publication, April 1, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.58">doi:10.1038/mt.2008.58</a>
</p>
<p>Authors: Ta-Chiang Liu, Pedro Castelo-Branco, Samuel D Rabkin
&amp; Robert L Martuza</p>
]]></content:encoded>
<dc:title>Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects</dc:title>
<dc:creator>Ta-Chiang Liu</dc:creator>
<dc:creator>Pedro Castelo-Branco</dc:creator>
<dc:creator>Samuel D Rabkin</dc:creator>
<dc:creator>Robert L Martuza</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.58</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 1, 2008</dc:source>
<dc:date>April 1, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.54">
<title>Use of A U16 snoRNA-containing Ribozyme Library to Identify Ribozyme Targets in HIV-1</title>
<link>http://dx.doi.org/10.1038/mt.2008.54</link>
<content:encoded><![CDATA[

<p>
<b>Use of A U16 snoRNA-containing Ribozyme Library to Identify Ribozyme Targets in HIV-1</b>
</p>
<p>Molecular Therapy advance online publication, April 1, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.54">doi:10.1038/mt.2008.54</a>
</p>
<p>Authors: Hoshang J Unwalla, Haitang Li, Shi-Yang Li, Danny Abad
&amp; John J Rossi</p>
]]></content:encoded>
<dc:title>Use of A U16 snoRNA-containing Ribozyme Library to Identify Ribozyme Targets in HIV-1</dc:title>
<dc:creator>Hoshang J Unwalla</dc:creator>
<dc:creator>Haitang Li</dc:creator>
<dc:creator>Shi-Yang Li</dc:creator>
<dc:creator>Danny Abad</dc:creator>
<dc:creator>John J Rossi</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.54</dc:identifier>
<dc:source>Molecular Therapy advance online publication, April 1, 2008</dc:source>
<dc:date>April 1, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>April 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.57">
<title>Effect of Late-stage Therapy on Disease Progression in AAV-mediated Rescue of Photoreceptor Cells in the Retinoschisin-deficient Mouse</title>
<link>http://dx.doi.org/10.1038/mt.2008.57</link>
<content:encoded><![CDATA[

<p>
<b>Effect of Late-stage Therapy on Disease Progression in AAV-mediated Rescue of Photoreceptor Cells in the Retinoschisin-deficient Mouse</b>
</p>
<p>Molecular Therapy advance online publication, March 25, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.57">doi:10.1038/mt.2008.57</a>
</p>
<p>Authors: Andreas Janssen, Seok H Min, Laurie L Molday, Naoyuki Tanimoto, Mathias W Seeliger, William W Hauswirth, Robert S Molday
&amp; Bernhard HF Weber</p>
]]></content:encoded>
<dc:title>Effect of Late-stage Therapy on Disease Progression in AAV-mediated Rescue of Photoreceptor Cells in the Retinoschisin-deficient Mouse</dc:title>
<dc:creator>Andreas Janssen</dc:creator>
<dc:creator>Seok H Min</dc:creator>
<dc:creator>Laurie L Molday</dc:creator>
<dc:creator>Naoyuki Tanimoto</dc:creator>
<dc:creator>Mathias W Seeliger</dc:creator>
<dc:creator>William W Hauswirth</dc:creator>
<dc:creator>Robert S Molday</dc:creator>
<dc:creator>Bernhard HF Weber</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.57</dc:identifier>
<dc:source>Molecular Therapy advance online publication, March 25, 2008</dc:source>
<dc:date>March 25, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>March 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.61">
<title>Lentiviral Vector&#8211;mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats</title>
<link>http://dx.doi.org/10.1038/mt.2008.61</link>
<content:encoded><![CDATA[

<p>
<b>Lentiviral Vector&#8211;mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats</b>
</p>
<p>Molecular Therapy advance online publication, March 25, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.61">doi:10.1038/mt.2008.61</a>
</p>
<p>Authors: Kazuo Niwano, Masashi Arai, Norimichi Koitabashi, Atai Watanabe, Yasuhiro Ikeda, Hiroyuki Miyoshi
&amp; Masahiko Kurabayashi</p>
]]></content:encoded>
<dc:title>Lentiviral Vector&#8211;mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats</dc:title>
<dc:creator>Kazuo Niwano</dc:creator>
<dc:creator>Masashi Arai</dc:creator>
<dc:creator>Norimichi Koitabashi</dc:creator>
<dc:creator>Atai Watanabe</dc:creator>
<dc:creator>Yasuhiro Ikeda</dc:creator>
<dc:creator>Hiroyuki Miyoshi</dc:creator>
<dc:creator>Masahiko Kurabayashi</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.61</dc:identifier>
<dc:source>Molecular Therapy advance online publication, March 25, 2008</dc:source>
<dc:date>March 25, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>March 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.59">
<title>Heterologous Boosting of Recombinant Adenoviral Prime Immunization With a Novel Vesicular Stomatitis Virus&#8211;vectored Tuberculosis Vaccine</title>
<link>http://dx.doi.org/10.1038/mt.2008.59</link>
<content:encoded><![CDATA[

<p>
<b>Heterologous Boosting of Recombinant Adenoviral Prime Immunization With a Novel Vesicular Stomatitis Virus&#8211;vectored Tuberculosis Vaccine</b>
</p>
<p>Molecular Therapy advance online publication, March 25, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.59">doi:10.1038/mt.2008.59</a>
</p>
<p>Authors: Elizabeth K Roediger, Kapilan Kugathasan, XiZhong Zhang, Brian D Lichty
&amp; Zhou Xing</p>
]]></content:encoded>
<dc:title>Heterologous Boosting of Recombinant Adenoviral Prime Immunization With a Novel Vesicular Stomatitis Virus&#8211;vectored Tuberculosis Vaccine</dc:title>
<dc:creator>Elizabeth K Roediger</dc:creator>
<dc:creator>Kapilan Kugathasan</dc:creator>
<dc:creator>XiZhong Zhang</dc:creator>
<dc:creator>Brian D Lichty</dc:creator>
<dc:creator>Zhou Xing</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.59</dc:identifier>
<dc:source>Molecular Therapy advance online publication, March 25, 2008</dc:source>
<dc:date>March 25, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>March 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.56">
<title>Extended Transgene Expression From a Nonintegrating Adenoviral Vector Containing Retroviral Elements</title>
<link>http://dx.doi.org/10.1038/mt.2008.56</link>
<content:encoded><![CDATA[

<p>
<b>Extended Transgene Expression From a Nonintegrating Adenoviral Vector Containing Retroviral Elements</b>
</p>
<p>Molecular Therapy advance online publication, March 25, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.56">doi:10.1038/mt.2008.56</a>
</p>
<p>Authors: Changyu Zheng, Joseph M Vitolo, Weitian Zhang, Fumi Mineshiba, John A Chiorini
&amp; Bruce J Baum</p>
]]></content:encoded>
<dc:title>Extended Transgene Expression From a Nonintegrating Adenoviral Vector Containing Retroviral Elements</dc:title>
<dc:creator>Changyu Zheng</dc:creator>
<dc:creator>Joseph M Vitolo</dc:creator>
<dc:creator>Weitian Zhang</dc:creator>
<dc:creator>Fumi Mineshiba</dc:creator>
<dc:creator>John A Chiorini</dc:creator>
<dc:creator>Bruce J Baum</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.56</dc:identifier>
<dc:source>Molecular Therapy advance online publication, March 25, 2008</dc:source>
<dc:date>March 25, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>March 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/sj.mt.6300415">
<title>Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis</title>
<link>http://dx.doi.org/10.1038/sj.mt.6300415</link>
<content:encoded><![CDATA[

<p>
<b>Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis</b>
</p>
<p>Molecular Therapy advance online publication, February 12, 2008. <a href="http://dx.doi.org/10.1038/sj.mt.6300415">doi:10.1038/sj.mt.6300415</a>
</p>
<p>Authors: Michael Chang, Jonathan D Cooper, David E Sleat, Seng H Cheng, James C Dodge, Marco A Passini, Peter Lobel
&amp; Beverly L Davidson</p>
]]></content:encoded>
<dc:title>Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis</dc:title>
<dc:creator>Michael Chang</dc:creator>
<dc:creator>Jonathan D Cooper</dc:creator>
<dc:creator>David E Sleat</dc:creator>
<dc:creator>Seng H Cheng</dc:creator>
<dc:creator>James C Dodge</dc:creator>
<dc:creator>Marco A Passini</dc:creator>
<dc:creator>Peter Lobel</dc:creator>
<dc:creator>Beverly L Davidson</dc:creator>
<dc:identifier>doi:10.1038/sj.mt.6300415</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 12, 2008</dc:source>
<dc:date>February 12, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 12, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.7">
<title>Gene Therapy of &#946;c-Deficient Pulmonary Alveolar Proteinosis (&#946;c-PAP): Studies in a Murine in vivo Model</title>
<link>http://dx.doi.org/10.1038/mt.2008.7</link>
<content:encoded><![CDATA[

<p>
<b>Gene Therapy of &#946;c-Deficient Pulmonary Alveolar Proteinosis (&#946;c-PAP): Studies in a Murine in vivo Model</b>
</p>
<p>Molecular Therapy advance online publication, February 12, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.7">doi:10.1038/mt.2008.7</a>
</p>
<p>Authors: Veronika Kleff, Ursula R Sorg, Carsten Bury, Takuji Suzuki, Ina Rattmann, Moran Jerabek-Willemsen, Christopher Poremba, Michael Flasshove, Bertram Opalka, Bruce Trapnell, Uta Dirksen
&amp; Thomas Moritz</p>
]]></content:encoded>
<dc:title>Gene Therapy of &#946;c-Deficient Pulmonary Alveolar Proteinosis (&#946;c-PAP): Studies in a Murine in vivo Model</dc:title>
<dc:creator>Veronika Kleff</dc:creator>
<dc:creator>Ursula R Sorg</dc:creator>
<dc:creator>Carsten Bury</dc:creator>
<dc:creator>Takuji Suzuki</dc:creator>
<dc:creator>Ina Rattmann</dc:creator>
<dc:creator>Moran Jerabek-Willemsen</dc:creator>
<dc:creator>Christopher Poremba</dc:creator>
<dc:creator>Michael Flasshove</dc:creator>
<dc:creator>Bertram Opalka</dc:creator>
<dc:creator>Bruce Trapnell</dc:creator>
<dc:creator>Uta Dirksen</dc:creator>
<dc:creator>Thomas Moritz</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.7</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 12, 2008</dc:source>
<dc:date>February 12, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 12, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/sj.mt.6300420">
<title>Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of &#945;-Tocopherol</title>
<link>http://dx.doi.org/10.1038/sj.mt.6300420</link>
<content:encoded><![CDATA[

<p>
<b>Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of &#945;-Tocopherol</b>
</p>
<p>Molecular Therapy advance online publication, February 12, 2008. <a href="http://dx.doi.org/10.1038/sj.mt.6300420">doi:10.1038/sj.mt.6300420</a>
</p>
<p>Authors: Kazutaka Nishina, Toshinori Unno, Yoshitaka Uno, Takayuki Kubodera, Tadashi Kanouchi, Hidehiro Mizusawa
&amp; Takanori Yokota</p>
]]></content:encoded>
<dc:title>Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of &#945;-Tocopherol</dc:title>
<dc:creator>Kazutaka Nishina</dc:creator>
<dc:creator>Toshinori Unno</dc:creator>
<dc:creator>Yoshitaka Uno</dc:creator>
<dc:creator>Takayuki Kubodera</dc:creator>
<dc:creator>Tadashi Kanouchi</dc:creator>
<dc:creator>Hidehiro Mizusawa</dc:creator>
<dc:creator>Takanori Yokota</dc:creator>
<dc:identifier>doi:10.1038/sj.mt.6300420</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 12, 2008</dc:source>
<dc:date>February 12, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 12, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/mt.2008.11">
<title>Bovine Adenoviral Vector&#8211;based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus</title>
<link>http://dx.doi.org/10.1038/mt.2008.11</link>
<content:encoded><![CDATA[

<p>
<b>Bovine Adenoviral Vector&#8211;based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus</b>
</p>
<p>Molecular Therapy advance online publication, February 12, 2008. <a href="http://dx.doi.org/10.1038/mt.2008.11">doi:10.1038/mt.2008.11</a>
</p>
<p>Authors: Neetu Singh, Aseem Pandey, Lakshmi Jayashankar
&amp; Suresh K Mittal</p>
]]></content:encoded>
<dc:title>Bovine Adenoviral Vector&#8211;based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus</dc:title>
<dc:creator>Neetu Singh</dc:creator>
<dc:creator>Aseem Pandey</dc:creator>
<dc:creator>Lakshmi Jayashankar</dc:creator>
<dc:creator>Suresh K Mittal</dc:creator>
<dc:identifier>doi:10.1038/mt.2008.11</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 12, 2008</dc:source>
<dc:date>February 12, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 12, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/sj.mt.6300416">
<title>Ranibizumab for Macular Edema Due to Retinal Vein Occlusions; Implication of VEGF as a Critical Stimulator</title>
<link>http://dx.doi.org/10.1038/sj.mt.6300416</link>
<content:encoded><![CDATA[

<p>
<b>Ranibizumab for Macular Edema Due to Retinal Vein Occlusions; Implication of VEGF as a Critical Stimulator</b>
</p>
<p>Molecular Therapy advance online publication, February 5, 2008. <a href="http://dx.doi.org/10.1038/sj.mt.6300416">doi:10.1038/sj.mt.6300416</a>
</p>
<p>Authors: Peter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, Quan Dong Nguyen, Howard Ying, Diana V Do, Edward Quinlan, Ingrid Zimmer-Galler, Julia A Haller, Sharon D Solomon, Jennifer U Sung, Yasmin Hadi, Kashif A Janjua, Nida Jawed, David F Choy
&amp; Joseph R Arron</p>
]]></content:encoded>
<dc:title>Ranibizumab for Macular Edema Due to Retinal Vein Occlusions; Implication of VEGF as a Critical Stimulator</dc:title>
<dc:creator>Peter A Campochiaro</dc:creator>
<dc:creator>Gulnar Hafiz</dc:creator>
<dc:creator>Syed Mahmood Shah</dc:creator>
<dc:creator>Quan Dong Nguyen</dc:creator>
<dc:creator>Howard Ying</dc:creator>
<dc:creator>Diana V Do</dc:creator>
<dc:creator>Edward Quinlan</dc:creator>
<dc:creator>Ingrid Zimmer-Galler</dc:creator>
<dc:creator>Julia A Haller</dc:creator>
<dc:creator>Sharon D Solomon</dc:creator>
<dc:creator>Jennifer U Sung</dc:creator>
<dc:creator>Yasmin Hadi</dc:creator>
<dc:creator>Kashif A Janjua</dc:creator>
<dc:creator>Nida Jawed</dc:creator>
<dc:creator>David F Choy</dc:creator>
<dc:creator>Joseph R Arron</dc:creator>
<dc:identifier>doi:10.1038/sj.mt.6300416</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 5, 2008</dc:source>
<dc:date>February 5, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 5, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/sj.mt.6300409">
<title>A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs</title>
<link>http://dx.doi.org/10.1038/sj.mt.6300409</link>
<content:encoded><![CDATA[

<p>
<b>A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs</b>
</p>
<p>Molecular Therapy advance online publication, February 5, 2008. <a href="http://dx.doi.org/10.1038/sj.mt.6300409">doi:10.1038/sj.mt.6300409</a>
</p>
<p>Authors: Xiancheng Chen, Xiaojuan Lin, Jianlei Zhao, Wei Shi, Heng Zhang, Yongsheng Wang, Bing Kan, Licheng Du, Baiding Wang, Yuquan Wei, Yi Liu
&amp; Xia Zhao</p>
]]></content:encoded>
<dc:title>A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs</dc:title>
<dc:creator>Xiancheng Chen</dc:creator>
<dc:creator>Xiaojuan Lin</dc:creator>
<dc:creator>Jianlei Zhao</dc:creator>
<dc:creator>Wei Shi</dc:creator>
<dc:creator>Heng Zhang</dc:creator>
<dc:creator>Yongsheng Wang</dc:creator>
<dc:creator>Bing Kan</dc:creator>
<dc:creator>Licheng Du</dc:creator>
<dc:creator>Baiding Wang</dc:creator>
<dc:creator>Yuquan Wei</dc:creator>
<dc:creator>Yi Liu</dc:creator>
<dc:creator>Xia Zhao</dc:creator>
<dc:identifier>doi:10.1038/sj.mt.6300409</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 5, 2008</dc:source>
<dc:date>February 5, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 5, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/sj.mt.6300407">
<title>Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer</title>
<link>http://dx.doi.org/10.1038/sj.mt.6300407</link>
<content:encoded><![CDATA[

<p>
<b>Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer</b>
</p>
<p>Molecular Therapy advance online publication, February 5, 2008. <a href="http://dx.doi.org/10.1038/sj.mt.6300407">doi:10.1038/sj.mt.6300407</a>
</p>
<p>Authors: Shengming Dai, Dong Wei, Zhen Wu, Xiangyang Zhou, Xiaomou Wei, Haixin Huang
&amp; Guisheng Li</p>
]]></content:encoded>
<dc:title>Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer</dc:title>
<dc:creator>Shengming Dai</dc:creator>
<dc:creator>Dong Wei</dc:creator>
<dc:creator>Zhen Wu</dc:creator>
<dc:creator>Xiangyang Zhou</dc:creator>
<dc:creator>Xiaomou Wei</dc:creator>
<dc:creator>Haixin Huang</dc:creator>
<dc:creator>Guisheng Li</dc:creator>
<dc:identifier>doi:10.1038/sj.mt.6300407</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 5, 2008</dc:source>
<dc:date>February 5, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 5, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/sj.mt.6300410">
<title>TAT-mediated Delivery of LAD Restores Pyruvate Dehydrogenase Complex Activity in the Mitochondria of Patients with LAD Deficiency</title>
<link>http://dx.doi.org/10.1038/sj.mt.6300410</link>
<content:encoded><![CDATA[

<p>
<b>TAT-mediated Delivery of LAD Restores Pyruvate Dehydrogenase Complex Activity in the Mitochondria of Patients with LAD Deficiency</b>
</p>
<p>Molecular Therapy advance online publication, February 5, 2008. <a href="http://dx.doi.org/10.1038/sj.mt.6300410">doi:10.1038/sj.mt.6300410</a>
</p>
<p>Authors: Matan Rapoport, Ann Saada, Orly Elpeleg
&amp; Haya Lorberboum-Galski</p>
]]></content:encoded>
<dc:title>TAT-mediated Delivery of LAD Restores Pyruvate Dehydrogenase Complex Activity in the Mitochondria of Patients with LAD Deficiency</dc:title>
<dc:creator>Matan Rapoport</dc:creator>
<dc:creator>Ann Saada</dc:creator>
<dc:creator>Orly Elpeleg</dc:creator>
<dc:creator>Haya Lorberboum-Galski</dc:creator>
<dc:identifier>doi:10.1038/sj.mt.6300410</dc:identifier>
<dc:source>Molecular Therapy advance online publication, February 5, 2008</dc:source>
<dc:date>February 5, 2008</dc:date>
<prism:publicationName>Molecular Therapy</prism:publicationName>
<prism:publicationDate>February 5, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
</rdf:RDF>
